HeraMED Past Earnings Performance

Past criteria checks 0/6

HeraMED's earnings have been declining at an average annual rate of -7.9%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 34.2% per year.

Key information

-7.9%

Earnings growth rate

26.9%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate34.2%
Return on equity-573.2%
Net Margin-1,381.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How HeraMED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:HMD Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-752
31 Mar 241-752
31 Dec 231-742
30 Sep 231-742
30 Jun 230-642
31 Mar 230-731
31 Dec 220-731
30 Sep 220-941
30 Jun 220-1032
31 Mar 220-932
31 Dec 210-832
30 Sep 210-732
30 Jun 210-532
31 Mar 210-532
31 Dec 200-432
30 Sep 200-532
30 Jun 200-531
31 Mar 200-532
31 Dec 190-431
30 Sep 190-641
30 Jun 190-641
31 Mar 190-641
31 Dec 180-531
30 Sep 180-321
30 Jun 180-111
31 Mar 180-110
31 Dec 170-110

Quality Earnings: HMD is currently unprofitable.

Growing Profit Margin: HMD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HMD is unprofitable, and losses have increased over the past 5 years at a rate of 7.9% per year.

Accelerating Growth: Unable to compare HMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: HMD has a negative Return on Equity (-573.18%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies